Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001779453-20-000005
Filing Date
2020-06-15
Accepted
2020-06-15 18:55:03
Documents
1
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6741
  Complete submission text file 0001779453-20-000005.txt   8637
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Issuer) CIK: 0001662774 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO CA 94111
Business Address
Boeding Chad (Reporting) CIK: 0001779451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38890 | Film No.: 20964537

Mailing Address ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO CA 94111
Business Address ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO CA 94111 415-433-3751
EPIQ Capital Group, LLC (Reporting) CIK: 0001779453 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38890 | Film No.: 20964536